BMKDF (Biomark Diagnostics) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Biomark Diagnostics ROE % Adjusted to Book Value?

Biomark Diagnostics's ROE % for the quarter that ended in Dec. 2024 was 0.00%. Biomark Diagnostics's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Biomark Diagnostics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

Biomark Diagnostics ROE % Adjusted to Book Value Historical Data

The historical data trend for Biomark Diagnostics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics ROE % Adjusted to Book Value Chart

Biomark Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Biomark Diagnostics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Biomark Diagnostics's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Biomark Diagnostics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomark Diagnostics's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's ROE % Adjusted to Book Value falls into.

Biomark Diagnostics ROE % Adjusted to Book Value Calculation

Biomark Diagnostics's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Biomark Diagnostics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Biomark Diagnostics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (OTCPK:BMKDF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

20B:Germany 20B:Germany BUX:Canada

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Biomark Diagnostics Headlines

No Headlines